These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 31265501)

  • 1. Erratum: Qin H, Cho M, Haso W, et al. Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.
    Blood; 2016 Sep; 128(10):1441. PubMed ID: 31265501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.
    Qin H; Cho M; Haso W; Zhang L; Tasian SK; Oo HZ; Negri GL; Lin Y; Zou J; Mallon BS; Maude S; Teachey DT; Barrett DM; Orentas RJ; Daugaard M; Sorensen PH; Grupp SA; Fry TJ
    Blood; 2015 Jul; 126(5):629-39. PubMed ID: 26041741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
    Gil M; Ramil F; AgÍs JA
    Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells.
    Reighard SD; Cranert SA; Rangel KM; Ali A; Gyurova IE; de la Cruz-Lynch AT; Tuazon JA; Khodoun MV; Kottyan LC; Smith DF; Brunner HI; Waggoner SN
    Cell Rep Med; 2020 Aug; 1(5):100080. PubMed ID: 33205070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [Corrigendum].
    Onco Targets Ther; 2020; 13():3045. PubMed ID: 32308435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA.
    Bai Y; Kan S; Zhou S; Wang Y; Xu J; Cooke JP; Wen J; Deng H
    Cell Discov; 2016; 2():15052. PubMed ID: 27462841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA.
    Bai Y; Kan S; Zhou S; Wang Y; Xu J; Cooke JP; Wen J; Deng H
    Cell Discov; 2016; 2():16032. PubMed ID: 27625791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to:
    Hum Gene Ther; 2019 Sep; 30(9):1176. PubMed ID: 31573391
    [No Abstract]   [Full Text] [Related]  

  • 9. Erratum: Clinical chimeric antigen receptor T-cell therapy: a new and promising treatment modality for glioblastoma.
    Brown MP; Ebert LM; Gargett T
    Clin Transl Immunology; 2021; 10(8):e1331. PubMed ID: 34401149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
    Abbott RC; Verdon DJ; Gracey FM; Hughes-Parry HE; Iliopoulos M; Watson KA; Mulazzani M; Luong K; D'Arcy C; Sullivan LC; Kiefel BR; Cross RS; Jenkins MR
    Clin Transl Immunology; 2021; 10(7):e1317. PubMed ID: 34295472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Medicine, Volume 95, Issue 23: Erratum.
    Medicine (Baltimore); 2016 Jul; 95(28):e0916. PubMed ID: 31265603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.
    Clin Transl Immunology; 2022; 11(11):e1429. PubMed ID: 36349202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips.
    J Vis Exp; 2019 May; (147):. PubMed ID: 31067212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Qin, W.,
    Qin W; Magnussen CG; Li S; Steffen LM; Xi B; Zhao M
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32854450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelin-targeting chimeric antigen receptor-modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma.
    Xu JY; Ye ZL; Jiang DQ; He JC; Ding YM; Li LF; Lv SQ; Wang Y; Jin HJ; Qian QJ
    Tumour Biol; 2017 Apr; 39(4):1010428317695949. PubMed ID: 28381173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of mutations in the DNA-binding domain of the oncoprotein Qin.
    Banerjee-Basu S; Baxevanis AD
    Mol Cancer Ther; 2002 Nov; 1(13):1237-41. PubMed ID: 12479705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
    J Neurochem; 2017 May; 141(3):473-474. PubMed ID: 28417467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum for the Research Article: "Dynamic conservation for migratory species" by M. Reynolds, B. L. Sullivan, E. Hallstein, S. Matsumoto, S. Kelling, M. Merrifield, D. Fink, A. Johnston, W. M. Hochachka, N. E. Bruns, M. E. Reiter, S. Veloz, C. Hickey, N. Elliot, L. Martin, J. W. Fitzpatrick, P. Spraycar, G. H. Golet, C. McColl and S. A. Morrison.
    Sci Adv; 2018 Mar; 4(3):eaat3915. PubMed ID: 29721535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum.
    Sci Technol Adv Mater; 2016; 17(1):188. PubMed ID: 27889790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Meneghini M, Melilli E, Martorell J, et al. Combining sensitive crossmatch assays with donor/recipient human leukocyte antigen eplet matching predicts living-donor kidney transplant outcome.
    Kidney Int Rep; 2019 Apr; 4(4):634. PubMed ID: 30993243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.